Pneumonia
The Redwood City, CA-based company markets the Karius test, a next-generation sequencing and artificial intelligence-powered option designed to screen blood for 1,000 pathogens, including bacteria, fungi, DNA viruses, and parasites. The test is being positioned for a range of applications, including complicated pneumonia, infections in immunocompromised patients, and endocarditis. February 24, 2020